News

Under the terms of the agreements, P&GP will access a wide range of discovery and preclinical expertise offered by Evotec, ranging from assay development, screening, medicinal and computational

The new drug is the first prescription insomnia treatment that has not been classified as a controlled substance by the US Drug Enforcement Administration. Rozerem has avoided the

The grant will fund a key preclinical efficacy study and support preparations for clinical trials. The company is targeting the start of clinical development in 2006-07. A previous

Swiss drugs giant Novartis AG had displaced Teva as the world’s biggest maker of generic drugs following its purchase of Germany’s Hexal and Hexal’s US unit Eon Labs

Schering-Plough will pay Millennium an upfront payment of $35.5 million and royalties over the US lifespan of Integrilin. In 2006 and 2007, minimum royalty payments for each year

Aderall XR is already approved for the treatment of attention deficit hyperactivity disorder (ADHA) in children aged 6 to 12, and also in adults aged 18 years and

Mars has apparently discovered how to replicate important cocoa compounds known as flavanols, which could present the pharmaceutical industry with a potential new generation of medications. Flavanols are

The pharmaceuticals division posted strong growth in the first half of 2005, with sales up 22% in local currencies (19% in Swiss francs; 25% in U.S. dollars). This

The drug is indicated for use in patients following bowel resection surgery, in order to reduce the risk of postoperative ileus, a condition where the intestine becomes incapable